Same Indication

Pembrolizumab vs Sildenafil

Pembrolizumab vs Sildenafil: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Sildenafil.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Sildenafil: Selective PDE5 inhibitor increasing cGMP.

Pharmacokinetics

Half-life: Pembrolizumab — 26 days; Sildenafil — 4 hours.

Chemical Properties

Molecular Formula: Sildenafil — C22H30N6O4S.

Molecular Weight: Sildenafil — 474.5800 g/mol.

Type: Pembrolizumab — Antibody; Sildenafil — Small molecule.